Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly FCF Margin of 26.55% in Q4 2025, up 31.41% quarter-over-quarter from 20.2% in Q3 2025, and up 467.0% on a YoY basis from 4.68% in Q4 2024.
Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's FCF Margin history runs 16 years deep, the most recent figure standing at 26.55% for Q4 2025.
- In Q4 2025, FCF Margin rose 467.0% year-over-year to 26.55%; the TTM figure through Dec 2025 stood at 24.21% (up 197.0% YoY), while the FY2025 annual figure was 21.38%, up 11.0% from the prior year.
- FCF Margin was 26.55% for Q4 2025 at Prestige Consumer Healthcare, up from 20.2% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 31.33% in Q2 2025 to a low of 16.69% in Q2 2023.
- Historically, FCF Margin has averaged 22.12% across 5 years, with a median of 21.52% in 2024.
- The sharpest annual moves came in 2021 and 2025: FCF Margin sank 646 bps in 2021, then jumped 1126 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 23.34% in 2021, then fell by 17 bps to 19.29% in 2022, then climbed by 27 bps to 24.57% in 2023, then decreased by 11 bps to 21.88% in 2024, then gained by 21 bps to 26.55% in 2025.
- The last three FCF Margin figures came in at 26.55% (Q4 2025), 20.2% (Q3 2025), and 31.33% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 26.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 20.20% |
| Jun 30, 2025 | 31.33% |
| Mar 31, 2025 | 19.68% |
| Dec 31, 2024 | 21.88% |
| Sep 30, 2024 | 23.88% |
| Jun 30, 2024 | 20.07% |
| Mar 31, 2024 | 23.02% |
| Dec 31, 2023 | 24.57% |
| Sep 30, 2023 | 20.79% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | 19.74% |
| Dec 31, 2022 | 19.29% |
| Sep 30, 2022 | 19.07% |
| Jun 30, 2022 | 20.65% |
| Mar 31, 2022 | 22.46% |
| Dec 31, 2021 | 23.34% |
| Sep 30, 2021 | 21.16% |
| Jun 30, 2021 | 25.19% |
| Mar 31, 2021 | 22.79% |